The initial mdr, supplemental follow up 1 and supplemental follow up 2 were submitted to the fda on time under manufacturing report number 3002037047-2020-00003.Upon confirmation of the reported product lot manufacturer, this report is being resubmitted under the correct manufacturer report number.The returned product was visually inspected, but only the locking collar and the cannula sheath were received.Batch records were reviewed and all testing results met specifications for this lot code at the time of release.Additionally, there were no deviations noted during the batch record review.Complaint trending was reviewed for the lot code provided.No similar complaint was found.A root cause could not be determined.Review of the records determined there were no deviations or comments related to product formulation that would indicate an issue with damaged units in regards to the cannula.The cannula component was used in five other finished good lots.There are no other complaints for any of the five lots that used the same cannula lot number.Syringe units are 100% visually inspected post-fill.Visual inspection and defect criteria are subjected to two 100% inspections prior to packaging.The qci inspections performed at final packaging prior to release met all criteria.Due to the lack of product returned regarding the observed cannula damage, no further assessment was performed.The complaint could not be confirmed based on the sample evaluation.Based on the investigation, the lack of additional complaints for this lot, the returned sample evaluation and the acceptable batch record review, no further action is warranted at this time.The manufacturer internal reference number is: (b)(4).
|